The fibromyalgia Impact Questionnaire: A useful tool in evaluating patients with post-Lyme disease syndrome

Arthritis Care and Research

Volumn 12, Issue 1, 1999, Pages 42-47

  Fallon, John ^a   Bujak, Danuta I ^b   Guardino, Sara ^c,d   Weinstein, Arthur ^c,d  

^a PACE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Fibromyalgia; Fibromyalgia Impact Questionnaire; Lyme disease; Post Lyme disease syndrome

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; EVALUATION; FATIGUE; FEMALE; FIBROMYALGIA; FUNCTIONAL ASSESSMENT; HUMAN; LYME DISEASE; MALE; MEMORY; MYALGIA; PAIN ASSESSMENT; PHYSICAL DISABILITY; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; WELLBEING;

EID: 0032731928     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199902)12:1<42::aid-art7>3.0.co;2-3     Document Type: Article

References (17)

1. Asch ES, Bujak DI, Weiss M, Peterson MGE, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 1994;21:454-61.
2. Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996;23:1392-7.
3. Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann Intern Med 1992;117:281-5.
4. Rahn DW, Malawista SE. Lyme disease. In: Koopman WJ, editor. Arthritis and allied conditions. 13th ed. Baltimore: Williams and Wilkins; 1997. p. 2321-39.
5. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;22:1438-44.
6. Pfister HW, Preac-Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM. Randomized comparison of ceftriaxone and cefotaxime in Lyme Nouroborreliosis. J Infect Dis 1991;163:311-8.
7. Steere AC, Dwyer ED, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990;323:219-23.
8. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I. Treatment of late Lyme Borreliosis. J Infect Dis 1994;29:255-61.
9. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;8:728-33.
10. Weinstein A, Dornbush RL, Guardino SD, Bujak DI, Norton D, Masdeu J, et al. Post Lyme syndrome and fibromyalgia share clinical, psychological, and neurocognitive features [abstract]. Arthritis Rheum 1997;40 Suppl 9:S45.
11. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
12. SPSS Inc. SPSS for Windows: base systems user's guide, release 6.0. Chicago: SPSS Inc.; 1993.
13. Polit D, Hungler B. Nursing research: principles and methods. 5th ed. New York: JB Lippincott; 1995.
14. Halperin JJ, Pass HL, Anand AK, Volkman DJ, Dattwyler RJ. Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci 1988:539:24-34.
15. Kaplan RF, Meadows ME, Vincent LC, Logician EL, Steere AC. Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 1992;42:1263-7.
16. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
17. Bujak DI, Weinstein A, Weinberg S. Cognitive appraisal as a predictor of outcome in early Lyme disease [abstract]. Arthritis Rheum 1997;40 Suppl 9:S222.